Correct. And I believe that $60B number aligns perfectly with 50% of the estimated 1.7M US patients express CCR5 (at the $70,000 price you mentioned).
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
Please do your own due diligence. All my posts and comments are not to be considered investment advice.